Draft Guidance Document - Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act
Health Canada is pleased to announce the release of the Draft Guidance Document – “Disclosure of Confidential Business Information under Paragraph 21.1(3)(c) of the Food and Drugs Act” for a 75-day stakeholder consultation.
How to Get Involved
This consultation is open for comment starting March 10, 2016 until May 24, 2016. Please select and read through the link below titled “consultation document”. Once read please submit your comments via email, fax or by mail to:
Resource Management and Operations Directorate
5th Floor, Room 545
Address Locator 20051
Graham Spry Building
250 Lanark Avenue
Interested parties are encouraged to provide comments and suggestions by May 24, 2016.
Reporting to Canadians
Health Canada will make the results of this consultation available on this web site.
If you have any questions, contact us at Resource Management and Operations Directorate.
Interested in our other consultations? Sign up and stay informed about topics that matter to you.
Report a problem or mistake on this page
- Date modified: